Dr. Jason Pogue contextualizes preliminary data looking at the #PETERPEN trial and other extended-spectrum beta-lactamase studies, which reopens the debate around carbapenem-sparing treatment options. #IDsky #Medsky
Watch the full interview here: www.contagionlive.com/view/further...